Financhill
Back

Oncternal Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
3

ONCT
Oncternal Therapeutics

Last Price:
1.71
Seasonality Move:
5.35%
Sell
26

NBY
NovaBay Pharmaceuticals

Last Price:
0.50
Seasonality Move:
-14.79%
Sell
3
Oncternal Therapeutics (ONCT) is a Sell

Is Oncternal Therapeutics a Buy, Sell or Hold?

  • The current Oncternal Therapeutics [ONCT] share price is $1.69. The Score for ONCT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • ONCT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ONCT Stock Price Chart

What is Oncternal Therapeutics's stock price today?

  • The Oncternal Therapeutics share price today is $1.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

ONCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 21.44 Sell
Chaikin Money Flow: 52731 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 4.81) Sell
Bollinger Bands (100): (4.62 - 8.82) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: -38478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.61 - 3.39) Sell

ONCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.52 Sell
20-day SMA: 3.61 Sell
50-day SMA: 5.08 Sell
200-day SMA: 7.77 Sell
8-day EMA: 2.3 Sell
20-day EMA: 3.3 Sell
50-day EMA: 4.73 Sell
200-day EMA: 7.26 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.89 Sell
200-day SMA: 3.84 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.97 Sell
200-day EMA: 8.42 Sell

Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $1.11 per share, an increase this year of $2.00 per share, and an increase next year of $2.22 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Oncternal Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):